Skip to main content
Fig. 2 | BMC Anesthesiology

Fig. 2

From: Prognostic value of endothelial biomarkers in refractory cardiogenic shock with ECLS: a prospective monocentric study

Fig. 2

Receiver operating characteristic curves (ROC) of discriminating mortality for (a) at day 0, (b) at day 1, (c) at day 2, and (d) combination of angiopoietin-2 at day 0 and VEGF at day 2. The area under ROC of angiopoietin-2 at day 0 + VEGF at day 2 was 0.854 (95% confidence interval, 0.645 to 0.965). VEGF, vascular endothelial growth factor; Ang, angiopoietin

Back to article page